[HTML] frontiersin.org

[HTML][HTML] Risk factors for the comorbidity of hypertension and renal cell carcinoma in the cardio-oncologic era and treatment for tumor-induced hypertension

Z Ba, Y Xiao, M He, D Liu, H Wang, H Liang… - Frontiers in …, 2022 - frontiersin.org
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …
被引用次数：12 相关文章

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Z Ba, Y Xiao, M He, D Liu, H Wang… - Frontiers in …, 2022 - europepmc.org
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …
[HTML] nih.gov

[HTML][HTML] Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Z Ba, Y Xiao, M He, D Liu, H Wang… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension

Z Ba, Y Xiao, M He, D Liu, H Wang… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …

Risk Factors for the Comorbidity of Hypertension and Renal Cell Carcinoma in the Cardio-Oncologic Era and Treatment for Tumor-Induced Hypertension.

Z Ba, Y Xiao, M He, D Liu, H Wang… - Frontiers in …, 2022 - europepmc.org
Advances in tumor diagnosis and treatment, especially the use of targeted therapies, have
remarkably improved the survival rate of patients with renal cell carcinoma (RCC) …